182 related articles for article (PubMed ID: 15928675)
1. Pharmacokinetic variability of anticancer agents.
Undevia SD; Gomez-Abuin G; Ratain MJ
Nat Rev Cancer; 2005 Jun; 5(6):447-58. PubMed ID: 15928675
[TBL] [Abstract][Full Text] [Related]
2. The importance of pharmacokinetic limited sampling models for childhood cancer drug development.
Panetta JC; Iacono LC; Adamson PC; Stewart CF
Clin Cancer Res; 2003 Nov; 9(14):5068-77. PubMed ID: 14613983
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children.
Rodman JH; Relling MV; Stewart CF; Synold TW; McLeod H; Kearns C; Stute N; Crom WR; Evans WE
Semin Oncol; 1993 Feb; 20(1):18-29. PubMed ID: 8475406
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics and pharmacodynamics of anticancer agents in pediatric patients (review).
Knoester PD; Underberg WJ; Beijnen JH
Anticancer Res; 1993; 13(5C):1795-808. PubMed ID: 8267385
[TBL] [Abstract][Full Text] [Related]
5. Interpreting disparate responses to cancer therapy: the role of human population genetics.
Maitland ML; DiRienzo A; Ratain MJ
J Clin Oncol; 2006 May; 24(14):2151-7. PubMed ID: 16682733
[TBL] [Abstract][Full Text] [Related]
6. Improving the use of anticancer drugs: clinical pharmacokinetic approaches.
Collins JM
Isr J Med Sci; 1988; 24(9-10):483-7. PubMed ID: 3204004
[TBL] [Abstract][Full Text] [Related]
7. [Practical control methods for the dose individualization of anticancer drugs].
Wang LY; Tang ZQ; Feng FY
Ai Zheng; 2002 Dec; 21(12):1382-5. PubMed ID: 12520753
[TBL] [Abstract][Full Text] [Related]
8. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
9. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
Mathijssen RH; van Schaik RH
Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399
[TBL] [Abstract][Full Text] [Related]
10. Microdialysis: an in vivo approach for measuring drug delivery in oncology.
Brunner M; Müller M
Eur J Clin Pharmacol; 2002 Jul; 58(4):227-34. PubMed ID: 12136367
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.
Guo F; Letrent SP; Sharma A
Cancer Chemother Pharmacol; 2007 Nov; 60(6):799-809. PubMed ID: 17285315
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of heated intraperitoneal oxaliplatin.
Ferron G; Dattez S; Gladieff L; Delord JP; Pierre S; Lafont T; Lochon I; Chatelut E
Cancer Chemother Pharmacol; 2008 Sep; 62(4):679-83. PubMed ID: 18084764
[TBL] [Abstract][Full Text] [Related]
13. Population approaches in paediatrics.
Chatelut E
Fundam Clin Pharmacol; 2008 Dec; 22(6):575-8. PubMed ID: 19049657
[TBL] [Abstract][Full Text] [Related]
14. [Target selectivity of anticancer drugs].
Fattoruso SI; Di Lauro L; Conti F; Amodio A; Lopez M
Clin Ter; 2008; 159(3):189-206. PubMed ID: 18594750
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics and impaired organic functions].
Chatelut E
Bull Cancer; 2011 Nov; 98(11):1347-54. PubMed ID: 22024557
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and therapeutic drug monitoring of anticancer agents].
Marquet P; Rousseau A
Bull Cancer; 2008 Oct; 95(10):903-9. PubMed ID: 19004719
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment].
Tranchand B; Falandry C; You B; Girard P; Ribba B; Tod M; Freyer G
Bull Cancer; 2008 May; 95 FMC Onco():F21-7. PubMed ID: 18511363
[TBL] [Abstract][Full Text] [Related]
18. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics.
Aboel Dahab A; El-Hag D; Moutamed GM; Aboel Dahab S; Abuknesha R; Smith NW
Cancer Chemother Pharmacol; 2016 Sep; 78(3):465-89. PubMed ID: 27061417
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of cancer chemotherapy.
Alnaim L
J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
